07971459383

Change Language

KETHAN PHARMA DISTRIBUTORS
GST : 36ABMPO2384G1ZD

Our Products

Pharmaceutical Tablets

Pharmaceutical Injection

Pharmaceutical Capsules

Anti Cancer Injection

Mircera 50 Mcg Injection

Therapy Lotion

Cardiovascular Injection

Recombinant Tissue Plasminogen Activator For Injection 20 Mg Kit

Pharmaceutical Cream

Mouth Freshener Spray

X-Wet Saliva Supplement Mouth Spray

Oral Suspension

Megestrol Acetate Oral Suspension USP

Pharmaceutical Syrup

Curcuage Liquid

Paclitaxel Injection IP

Name: Paclitaxel Injection IP
Brand: KETHAN PHARMA DISTRIBUTORS
Price: 10460 INR
Availability: InStock

Price 10460 INR/ Vial

Get a Price/Quote

MOQ : 1 Vial

Paclitaxel Injection IP Specification

Salt Composition
Paclitaxel

Brand Name
Kansure

Dosage Form
Injection

Indication
Ovarian, breast and lung cancer

Pacakaging (Quantity Per Box)
1 vial

Origin of Medicine
India

Packaging Type
Box

Life Span
24 months

Drug Type
Cytotoxic

Ingredients
Paclitaxel

Physical Form
Liquid

Function
Antineoplastic agent

Recommended For
Cancer treatment

Dosage
260 mg

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
43.4 ml

Storage Instructions
Store below 25C, protected from light

Single-use vial
Yes

IV infusion only
Yes

Prescription required
Yes

Sterile preparation
Yes

Clear solution
Yes

No oral administration
Yes

Paclitaxel Injection IP Trade Information

Minimum Order Quantity
1 Vial

Payment Terms
Cash in Advance (CID)

Supply Ability
1000 Vials Per Month

Delivery Time
7 Days

Main Domestic Market
All India

About Paclitaxel Injection IP

Find the ineffable power of Kansure Paclitaxel Injection IP - a crowning solution in cancer therapeutics. Jump on this hot-selling, sterile single-use vial, purpose-built for intravenous infusion in adults. Its noble formulation as an antineoplastic agent makes it an invaluable asset in the fight against ovarian, breast, and lung cancers. Each 260 mg vial comes strictly on prescription, providing a clear, liquid solution crafted in India under meticulous standards. Store securely below 25C, shielded from light, to uphold its efficacy for a 24-month lifespan. Elevate patient care with Kansure.

Targeted Cancer Therapy with Kansure Paclitaxel Injection IP

Paclitaxel Injection IP, designed for intravenous infusion, specifically targets ovarian, breast, and lung cancers in adult patients. Its general use as a cytotoxic antineoplastic agent ensures direct, potent tumor cell attack, administered only under professional supervision. Its usage type-hospital setting via IV-delivers high precision, while the clear, sterile liquid form confirms pharmaceutical-grade preparation. Kansure's features, including single-use vials and strict dosage adherence, guarantee reliability and optimum results in clinical practice.

Certifications, Stock Status, and Sample Availability for Kansure Paclitaxel Injection IP

Stock ready and available for rapid, quick dispatch in both domestic mar and international market. Kansure Paclitaxel Injection IP meets stringent industry certifications, conforming to high-quality manufacturing protocols. Samples can be provided upon formal request, honoring a transparent sample policy for buyers and partners. Always packaged in unit boxes and sourced directly from certified Indian suppliers, Kansure ensures traceability, compliance, and quick turnaround for all orders, fostering trust among exporters, suppliers, and traders.

FAQ's of Paclitaxel Injection IP:

Q: How should Paclitaxel Injection IP be administered for optimal safety and efficacy?

A: Paclitaxel Injection IP is intended strictly for intravenous infusion and must be administered by trained healthcare professionals in a clinical setting. It should never be given orally and precise dosage guidelines from a physician must always be followed.

Q: What types of cancers is Kansure Paclitaxel Injection IP indicated for?

A: Kansure Paclitaxel Injection IP is indicated for the treatment of ovarian, breast, and lung cancer. It acts as a cytotoxic antineoplastic agent targeting cancerous cells to inhibit their growth and proliferation.

Q: When can clients expect product dispatch after placing an order?

A: Stock is ready for immediate and quick dispatch upon confirmation of order. Kansure ensures timely delivery for both domestic and international clients.

Q: Where should Paclitaxel Injection IP be stored to maintain its efficacy?

A: The vials must be stored in a cool environment, below 25C and protected from light, following strict storage instructions to preserve the medicine's stability and effectiveness.

Q: What is the shelf life of Kansure Paclitaxel Injection IP?

A: Each vial of Kansure Paclitaxel Injection IP maintains its effectiveness for 24 months when stored as per guidelines, ensuring extended usability for healthcare facilities.

Q: Is it possible to request a sample of the product prior to large orders?

A: Yes, samples of Kansure Paclitaxel Injection IP are available upon formal request. This allows potential buyers to assess quality and compliance before placing significant orders.

Tell us about your requirement